Diffuse idiopathic neuroendocrine cell hyperplasia causing severe airway obstruction in a patient with a carcinoid tumor

Respiration

Volumn 73, Issue 5, 2006, Pages 690-693

  Adams, Heiner ^a   Brack, Thomas ^a   Kestenholz, Peter ^a   Vogt, Peter ^a   Steinert D, Hans C ^a   Russi, Erich W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Hyperplasia; Lung volume reduction surgery; Neuroendocrine tumor; Obliterative bronchiolitis; Tumorlets

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BRONCHODILATING AGENT; FLUORODEOXYGLUCOSE F 18; PENTETREOTIDE IN 111;

ABNORMAL RESPIRATORY SOUND; ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRONCHIOLE; BRONCHOSCOPY; CANCER SURGERY; CARCINOID; CASE REPORT; CELL HYPERPLASIA; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; FEMALE; HUMAN; HYPERINFLATION; LUNG FUNCTION TEST; NEUROSECRETORY CELL; OXYGEN THERAPY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTIGRAPHY;

AIRWAY OBSTRUCTION; BRONCHIOLITIS OBLITERANS; CARCINOID TUMOR; FEMALE; HUMANS; HYPERPLASIA; LUNG NEOPLASMS; MIDDLE AGED; NEUROENDOCRINE TUMORS; RESPIRATORY MUCOSA;

EID: 33749245279     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088007     Document Type: Article

References (13)

1. DeRose JJ Jr, Argenziano M, El Amir N, Jellen PA, Gorenstein LA, Steinglass KM, et al: Lung reduction operation and resection of pulmonary nodules in patients with severe emphysema. Ann Thorac Surg 1998;65:314-318.
2. Aguayo SM, Miller YE, Waldron JA Jr, Bogin RM, Sunday ME, Staton GW Jr, et al: Brief report: Idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med 1992;327:1285-1288.
3. Miller RR, Muller NL: Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors. Am J Surg Pathol 1995;19:653-658.
4. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al: A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073.
5. Bloch KE, Russi EW, Weder W: Patient selection for lung volume reduction surgery: Is outcome predictable? Semin Thorac Cardiovasc Surg 2002;14:371-380.
6. Bolliger CT: Evaluation of operability before lung resection. Curr Opin Pulm Med 2003;9:321-326.
7. Edwards JG, Duthie DJ, Waller DA: Lobar volume reduction surgery: A method of increasing the lung cancer resection rate in patients with emphysema. Thorax 2001;56:791-795.
8. Gosney JR: Pulmonary neuroendocrine cell system in pediatric and adult lung disease. Microsc Res Tech 1997;37:107-113.
9. Lee JS, Brown KK, Cool C, Lynch DA: Diffuse pulmonary neuroendocrine cell hyperplasia: Radiologic and clinical features. J Comput Assist Tomogr 2002;26:180-184.
10. Armas OA, White DA, Erlandson RA, Rosai J: Diffuse idiopathic pulmonary neuroendocrine cell proliferation presenting as interstitial lung disease. Am J Surg Pathol 1995;19:963-970.
11. Miller MA, Mark GJ, Kanarek D: Multiple peripheral pulmonary carcinoids and tumorlets of carcinoid type, with restrictive and obstructive lung disease. Am J Med 1978;65:373-378.
12. Brown MJ, English J, Muller NL: Bronchiolitis obliterans due to neuroendocrine hyperplasia: High-resolution CT - Pathologic correlation. AJR Am J Roentgenol 1997;168:1561-1562.
13. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y: The new World Health Organization classification of lung tumours. Eur Respir J 2001;18:1059-1068.